A typology-based decisional framework to support market access and reimbursement decisions for personalised medicines
Publication typeJournal article
JournalValue in Health. The Journal of the International Society for Pharmacoeconomics and Outcomes Research
Publication Begin pageA661
Publication End pageA661
MetadataShow full item record
AbstractNew co-development approaches in personalized medicine challenge current decisional frameworks of health-technology access and reimbursement procedures. We aim to conceptualize an efficient typology-based decisional framework which takes into account the development and market access synchronism between therapeutic (Tx) and diagnostic (Dx) components of personalized medicines.
Knowledge Domain/IndustrySpecial Industries : Healthcare Management